Peregrine management leaving its shareholders in the dark. Apparently, we will have to wait for the next CC to get any information from Peregrine management how they plan to operate the company financially in the post Sunrise failure reality.
If they can't tell us how they will do so without sacrificing shareholder interests, I will take my huge loss and move on. Why wait for years enduring constant dilution on the uncertain likelihood of Bavi-immunotherapy success. Tried that with Bavi-chemo. Very expensive.
Market Data 
Markets 
AI
